نتایج جستجو برای: antiplatelet therapy

تعداد نتایج: 658043  

Journal: :iranian journal of diabetes and obesity 0
akram ghadiri-anari yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran amir hossein jafari-mehdiabad yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran mohammad afkhami-ardekani yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran mahboobeh rezapour yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran fahimeh chavoshzadeh-tafti yazd diabetes research center, shahid sadoughi university of medical science, yazd, iran

abstract objective: patients with type 2 diabetes mellitus (dm) have a markedly increased risk of cardiovascular morbidity and mortality. there are some recommendations for prescription of aspirin in these patients. our purpose was to determine aspirin usage rate in diabetic patients and to compare it in different ages and based upon cardiovascular disease (cvd) risk factors. materials and meth...

2013
Jonas Oldgren Lars Wallentin John H. Alexander Stefan James Birgitta Jönelid Gabriel Steg Johan Sundström

BACKGROUND Oral anticoagulation in addition to antiplatelet treatment after an acute coronary syndrome might reduce ischaemic events but increase bleeding risk. We performed a meta-analysis to evaluate the efficacy and safety of adding direct thrombin or factor-Xa inhibition by any of the novel oral anticoagulants (apixaban, dabigatran, darexaban, rivaroxaban, and ximelagatran) to single (aspir...

2014
Yun-Kyeong Cho Chang-Wook Nam Hyoung-Seob Park Hyuck-Jun Yoon Hyungseop Kim Seung-Ho Hur Yoon-Nyun Kim Jang-Hoon Lee Dong-Heon Yang Bong-Ryeol Lee Byung-Chun Jung Woong Kim Jong-Seon Park Jin-Bae Lee Kee-Sik Kim Kwon-Bae Kim

BACKGROUND/AIMS Combination single-pill therapy can improve cost-effectiveness in a typical medical therapy. However, there is a little evidence about the efficacy and tolerability of combination single-pill antiplatelet therapy after percutaneous coronary intervention (PCI) with drug-eluting stents (DES). METHODS From June to November 2012, in total, 142 patients who met the following criter...

2012
Karl Mischke Christian Knackstedt Nikolaus Marx

Anticoagulation represents the mainstay of therapy for most patients with atrial fibrillation. Patients on oral anticoagulation often require concomitant antiplatelet therapy, mostly because of coronary artery disease. After coronary stent implantation, dual antiplatelet therapy is necessary. However, the combination of oral anticoagulation and antiplatelet therapy increases the bleeding risk. ...

Journal: :Continuing Cardiology Education 2017

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید